Clinical Trials Browser

Unknown × Urinary Bladder Neoplasms × Fluorodeoxyglucose F18 × Clear all

NCT01222676 2013-08-12

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

Phase 2 Unknown

Urinary Bladder Neoplasms